FrancophonIA/ELRC3.0 huggingface dataset:
English: Levetiracetam Accord 250 mg film-coated tablets Levetiracetam Accord 500 mg film-coated tablets Levetiracetam Accord 750 mg film-coated tablets Levetiracetam Accord 1000 mg film-coated tablets
Estonian: Levetiracetam Accord 250 mg õhukese polümeerikattega tabletid Levetiracetam Accord 500 mg õhukese polümeerikattega tabletid Levetiracetam Accord 750 mg õhukese polümeerikattega tabletid Levetiracetam Accord 1000 mg õhukese polümeerikattega tabletid
English: 43.6% of the levetiracetam treated patients and 19.6% of the patients on placebo were considered as responders.
Estonian: Ravivastus esines 43,6 % levetiratsetaamiga ravitud ja 19,6 % platseeboga ravitud patsientidel.
English: If you take more Levetiracetam Accord than you should The possible side effects of an overdose of Levetiracetam are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.
Estonian: Kui te võtate Levetiracetam Accord'i rohkem kui ette nähtud Levetiracetam Accord'i üleannustamisel võib täheldada järgmisi kõrvaltoimeid: unisus, ärevus, agressiivsus, teadvuse häired, hingamise aeglustumine ja kooma.
English: The NOAEL (No Observed Adverse Effect Level) was 3600 mg /kg/day for pregnant female rats (x 12 the MRHD on a mg/m2basis) and 1200 mg /kg/day for fetuses.
Estonian: NOAEL (No Observed Adverse Effect Level) oli tiinetel emasrottidel 3600 mg/kg ööpäevas (mis vastab 12-kordsele soovituslikule maksimaalsele päevasele annusele inimesel mg/m2 kohta) ja loodetel 1200 mg/kg päevas.
English: A dose of 20 mg /kg/day titrating to 40 mg /kg/day for infants one month to less than six months and a dose of 25 mg /kg/day titrating to 50 mg /kg/day for infants and children 6 months to less than 4 years old, was use in this study.
Estonian: Uuringus kasutati raviskeemi 20 mg/kg ööpäevas kuni 40 mg/kg ööpäevas imikutel (1…6 kuu vanused) ja 25 mg/kg päevas kuni 50 mg/kg ööpäevas imikutel ja lastel (6 kuud…4-aastased).
English: Dosing adjustment for adult and adolescents patients weighing more than 50 kg with impaired renal function
Estonian: Annuse kohaldamine neerukahjustusega täiskasvanud patsientidele ja noorukitele kehakaaluga üle 50 kg:
English: No new safety concerns for levetiracetam were identified for infants less than 12 months of age with epilepsy.
Estonian: Alla 12 kuu vanustel epilepsiaga imikutel ei tuvastatud levetiratsetaami uusi ohutusealaseid muutusi.
English: With continued long-term treatment, 8.6% of the patients were seizure-free for at least 6 months and 7.8% were seizure-free for at least 1 year.
Estonian: Pikaajalise jätkuraviga saavutati 8,6% patsientidest krambivaba periood vähemalt 6 kuuks ja 7,8%-l vähemalt 1 aastaks.
English: In paediatric patients (4 to 16 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 198 patients and had a treatment duration of 14 weeks.
Estonian: Lastel (4...16-aastastel) tõestati levetiratsetaami efektiivsus platseebokontrollitud topeltpimeuuringus, mis hõlmas 198 patsienti ravi kestusega 14 nädalat.
English: Box of 10, 20, 30, 50, 60, 100, 200 tablets
Estonian: 30, 50, 60, 100, 200 tabletti
English: Iron oxide red (E172) Sunset yellow FCF (E110) 6.2 Incompatibilities Not applicable.
Estonian: Punane raudoksiid (E172) Päikeseloojangukollane FCF (E110)
English: The NOAEL was <200 mg/kg/day for the dams and 200 mg/kg/day for the foetuses (equal to the MRHD on a mg/m2 basis).
Estonian: NOAEL oli emasloomadel <200 mg/kg ööpäevas ja loodetel 200 mg/kg ööpäevas (mis vastab soovituslikule maksimaalsele päevasele annusele inimesel mg/m2 kohta).
English: In several cases of alopecia, recovery was observed when levetiracetam was discontinued.Bone marrow suppression was identified in some of the cases of pancytopenia.
Estonian: Mitmetel juhtudel täheldati pärast levetiratsetaami ärajätmist alopeetsia paranemist.
English: • in the treatment of partial onset seizures with or without secondary generalisation in adults,adolescents, children and infants from 1 month of age with epilepsy.
Estonian: • partsiaalsete krambihoogude korral, sekundaarse generaliseerumisega või ilma, epilepsiaga täiskasvanutele, noorukitele, lastele ja imikutele alates 1. kuu vanusest;
English: Polyvinyl alcohol Titanium dioxide (E171) Macrogol
Estonian: Polüvinüül alkohol Titaandioksiid (E171) Makrogool Talk
English: Therefore a 50 % reduction of the daily maintenance dose is recommended when the creatinine clearance is < 60 ml/min/1.73m2.
Estonian: Seetõttu on kreatiniini kliirensi korral <60 ml/min/1,73m2, soovitatav ööpäevast säilitusannust vähendada 50%.
English: Single pack containing 10, 20, 30, 50, 60, 100, 200 tablets.
Estonian: Üks pakend sisaldab 10, 20, 30, 50, 60, 100 või 200 tabletti.
English: (4) Following dialysis, a 3.5 to 7 mg /kg (0.035 to 0.07 ml/kg) supplemental dose is recommended.
Estonian: (4) Dialüüsi järgselt on soovitatav manustada täiendavalt 3,5...7 mg/kg (0,035...0,07 ml/kg).
English: Somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma were observed with Levetiracetam overdoses.
Estonian: Levetiratsetaami üleannustamisel täheldati unisust, agiteeritust, agressiooni, teadvuse häireid, hingamise depressiooni ja koomat.
English: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
Estonian: Täiendav ravi müokloonsete krambihoogudega täiskasvanutel ja juveniilse müokloonilise epilepsiaga noorukitel alates 12 aasta vanusest.
English: Following repeated oral dose administration (20 to 60 mg /kg/day) to epileptic children (4 to 12 years), levetiracetam was rapidly absorbed.
Estonian: Pärast korduva suukaudse annuse (20…60 mg/kg ööpäevas) manustamist epilepsiaga lastele (4…12aastased) imendus levetiratsetaam kiiresti.
English: 750 mg: polyvinyl alcohol, titanium dioxide (E171), macrogol, talc, iron oxide red (E172), sunset yellow FCF(E110)
Estonian: Polüvinüülalkohol, titaandioksiid (E171), makrogool, talk, punane raudoksiid (E172), päikeseloojangukollane FCF (E110)
English: (5) Following dialysis, a 5 to 10 mg /kg (0.05 to 0.10 ml/kg) supplemental dose is recommended.
Estonian: (5) Dialüüsi järgselt on soovitatav manustada täiendavalt 5...10 mg/kg (0,05...0,10 ml/kg).
English: Height (cm) x ks CLcr (ml/min/1.73 m2) = ----------------------------------Serum Creatinine (mg/dl)
Estonian: CLcr (ml/min/1,73 m2) = --------------------------------------Seerumi kreatiniin (mg/dl)
English: The patients were randomized to carbamazepine CR 400 - 1200 mg /day or levetiracetam 1000 - 3000 mg /day, the duration of the treatment was up to 121 weeks depending on the response.
Estonian: Patsiendid randomiseeriti karbamasepiin CR (400...1200 mg ööpäevas) või levetiratsetaami (1000...3000 mg ööpäevas) gruppi.
English: Muscular weakness, myalgia Rhabdomyolysis and blood creatine tissue disorders phosphokinase increased*
Estonian: Lihasnõrkus, müalgia Rabdomüolüüs ja vere kreatiniinfosfokinaasi taseme tõus*
English: • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
Estonian: • müoklooniliste krambihoogude korral täiskasvanutele ja noorukitele alates 12 aasta vanusest, kellel on müoklooniline epilepsia;
English: Thrombocytopenia, leukopenia Pancytopenia, neutropenia, agranulocytosis
Estonian: Pantsütopeenia, neutropeenia, agranulotsütoos
English: Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Estonian: Levetiratsetaam on näidustatud monoteraapiana partsiaalsete krambihoogude, sekundaarse generaliseerumisega või ilma, raviks esmaselt diagnoositud epilepsiaga täiskasvanutele ja noorukitele alates 16 aasta vanusest.
English: (3) A 15 mg /kg (0.15 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Estonian: (3) Soovitatav on ravi esimesel päeval kasutada algannust 15 mg/kg (0,15 ml/kg) levetiratsetaami.
English: Levetiracetam Accord is used
Estonian: Ravimit Levetiracetam Accord kasutatakse:
English: (2) A 10.5 mg /kg (0.105 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Estonian: (2) Soovitatav on ravi esimesel päeval kasutada algannust 10,5 mg/kg (0,105 ml/kg) levetiratsetaami.
English: Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy
Estonian: Täiendravi partsiaalsete krampide puhul koos sekundaarse generaliseerumisega või ilma, epilepsiaga täiskasvanutel, noorukitel, lastel ja imikutel alates 1. elukuust.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Estonian: MINIMAALSED ANDMED, MIS PEAVAD OLEMA BLISTER- VÕI RIBAPAKENDIL PVC/alu blister
English: Children and adolescents - Levetiracetam Accord is not indicated in children and adolescents below 16 years on its own
Estonian: • Levetiracetam Accord ei ole näidustatud lastele ja alla 16-aastastele noorukitele ainsa ravimina (monoteraapia).
English: In this study, levetiracetam, dose was 3000 mg /day given in 2 divided doses.
Estonian: Selles uuringus anti levetiratsetaami 3000 mg ööpäevas, jagatuna kaheks annuseks.
English: 7 to 14 mg /kg (0.07 to 0.14 ml/kg)once daily (2)
Estonian: 7...14 mg/kg (0,07...0,14 ml/kg) üks kord päevas (2) (4)
English: How to take Levetiracetam Accord
Estonian: Kuidas Levetiracetam Accord'i kasutada
English: • skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis).
Estonian: laiaulatuslik lööve villide ja naha koorumisega, eriti suu, nina, silma de ja genitaalide piirkonnas (Stevensi-Johnsoni sündroom) ning raskeim vorm, mis põhjustab naha koorumist rohkem kui, kui 30%-l nahapinnast (toksiline epidermaalne nekrolüüs).
English: - If you notice any slow down in the growth or unexpected puberty development of your child, please contact your doctor - A small number of people being treated with anti-epileptics such as Levetiracetam Accord have had thoughts of harming or killing themselves.
Estonian: • kui te täheldate oma lapse kasvu aeglustumist või ootamatut puberteedi arengut, võtke palun arstiga ühendust;
English: INFORMATION IN BRAILLE Levetiracetam Accord 1000 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Levetiracetam Accord 1000 mg
English: 0.20 ml/kg) once daily (3) (5) (1) Levetiracetam oral solution should be used for doses under 250 mg, for doses not multiple of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets.
Estonian: (1) Levetiratsetaami suukaudset lahust kasutada alla 250 mg annuse korral ja olukorras, mil soovitatud annus ei ole saavutatav mitme 250 mg tableti koosmanustamisel ning patsientidel, kes ei ole võimelised tablette neelama.
English: Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
Estonian: Täiendav ravi idiopaatilise generaliseerunud epilepsia primaarselt generaliseerunud toonilisklooniliste krambihoogudega täiskasvanutel ja üle 12- aastastel lastel.
English: Your doctor will prescribe the most appropriate pharmaceutical form of levetiracetam according to the age, weight and dose.
Estonian: Arst peab välja kirjutama vanusele, kehakaalule ja annusele kõige sobivama Levetiracetam Accord'i ravimvormi.
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam Accord 500 mg film-coated tablets Levetiracetam
Estonian: RAVIMPREPARAADI NIMETUS Levetiracetam Accord 500 mg õhukese polümeerikattega tabletid Levetiratsetaam
English: See leaflet for further information.
Estonian: Täiendav teave pakendi infolehel.
English: Levetiracetam oral solution is the preferred formulation for use in infants and children under the age of 6 years.
Estonian: Suukaudne lahus on sobivam ravimvorm imikutele ja alla 6-aastastele lastele.
English: Common: may affect up to 1 in 10 people
Estonian: Sage (võib esineda kuni ühel inimesel 10-st):
English: 7 to 21 mg /kg (0.07 to 0.21 ml/kg) twice daily
Estonian: 7...21 mg/kg (0,07...0,21 ml/kg) kaks korda ööpäevas
English: The blisters are further packed in to carton with leaflet in pack size of 10, 20, 30, 50, 60, 100 and 200 tablets per pack.
Estonian: Blistrid on pakendatud pakendi infolehte ja 10, 20, 30, 50, 60, 100 või 200 tabletti sisaldavatesse karpidesse.
English: (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration);
Estonian: • paresteesia (surinad), tähelepanuhäired (kontsentreerumisvõime kadu);
English: Rare: may affect up to 1 in 1,000 people
Estonian: Harv (võib esineda kuni ühel inimesel 1000-st):
English: 500 mg: polyvinyl alcohol, titanium dioxide (E171), macrogol, talc, iron oxide yellow (E172)
Estonian: Polüvinüülalkohol, titaandioksiid (E171), makrogool, talk, kollane raudoksiid (E172)
English: If you get any side effects talk to your doctor or pharmacist.
Estonian: - Kui teil tekib ükskõik milline kõrvaltoimetest, pidage nõu oma arsti või apteekriga.
English: 10 to 20 mg /kg (0.10 to
Estonian: 10...20 mg/kg
English: INFORMATION IN BRAILLE Levetiracetam Accord 750 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Levetiracetam Accord 750 mg
English: 10 to 20 mg /kg (0.10 to 0.20 ml/kg) twice daily
Estonian: 10...20 mg/kg (0,10...0,20 ml/kg) kaks korda ööpäevas
English: encephalopathy
Estonian: Retseptiravim
English: Levetiracetam Accord 750 mg film-coated tablets Pink coloured, oval, biconvex, debossed ‘L 66' and break line on one side and plain on the other side.
Estonian: Levetiracetam Accord 750 mg õhukese polümeerikattega tabletid Roosa, ovaalse kujuga kaksikkumer tablett, mille ühele küljele on pressitud märgistus „L66” ja poolitusjoon.
English: INFORMATION IN BRAILLE Levetiracetam Accord 250 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Levetiracetam Accord 250 mg
English: Dose in infants (1 month to 23 months), children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg
Estonian: • Annus imikutele (1...23 kuud), lastele (2…11-aastased) ja noorukitele (12...17-aastased) kehakaaluga alla 50 kg:
English: How to store Levetiracetam Accord
Estonian: Kuidas Levetiracetam Accord säilitada
English: 3.5 to 7 mg /kg (0.035 to 0.07 ml/kg) twice daily
Estonian: 3,5...7 mg/kg (0,035...0,07 ml/kg) kaks korda ööpäevas
English: For 250mg:
Estonian: 250 mg:
English: The CLcr in ml/min/1.73 m2 may be estimated from serum creatinine (mg/dl) determination, for young adolescents,children and infants, using the following formula (Schwartz formula):
Estonian: Noorukite, laste ja imikute CLcr ml/min/1,73 m2 võib määrata seerumi kreatiniinisisalduse järgi
English: 1000 mg: polyvinyl alcohol, titanium dioxide (E171), macrogol, talc
Estonian: Polüvinüülalkohol, titaandioksiid (E171), makrogool, talk
English: Important information about some of the ingredients of Levetiracetam Accord Levetiracetam Accord 750 mg film-coated tablet contains sunset yellow FCF (E110) colouring agent which may cause allergic reactions.
Estonian: Levetiracetam Accord´i 750 mg tabletid sisaldavad värvainet päikeseloojangukollane FCF (E110).
English: Levetiracetam Accord 500 mg film-coated tablets Yellow coloured, oval, biconvex, debossed ‘L 65' and break line on one side and plain on the other side.
Estonian: Levetiracetam Accord 500 mg õhukese polümeerikattega tabletid Kollane, ovaalse kujuga kaksikkumer tablett, mille ühele küljele on pressitud märgistus „L65” ja poolitusjoon.
English: Levetiracetam Accord 500 mg film-coated tablets Each film-coated tablet contains 500 mg levetiracetam
Estonian: Levetiracetam Accord 500 mg õhukese polümeerikattega tabletid Üks õhukese polümeerikattega tablett sisaldab 500 mg levetiratsetaami.
English: 5 to 15 mg /kg (0.05 to 0.15 ml/kg) twice daily
Estonian: 5...15 mg/kg (0,05...0,15 ml/kg) kaks korda ööpäevas
English: METHOD AND ROUTE OF ADMINISTRATION
Estonian: MANUSTAMISVIIS JA -TEE (D)
English: Neonatal and juvenile animal studies in rats and dogs demonstrated that there were no adverse effects seen in any of the standard developmental or maturation endpoints at doses up to 1800 mg/kg/day (x6-17 the MRHD on a mg/m2 basis).
Estonian: Neonataalsete ja juveniilsete katseloomadega (rotid, koerad) läbiviidud uuringud annuste puhul kuni 1800 mg/kg ööpäevas (mis on 6…17-kordne soovituslik maksimaalne ööpäevane annus inimesel mg/m2 kohta) näitasid, et kōrvalekaldeid katseloomade arengu ja küpsuse tulemusnäitajates ei tekkinud.
English: 7 to 14 mg /kg (0.07 to 0.14 ml/kg) twice daily
Estonian: 7...14 mg/kg (0,07...0,14 ml/kg) kaks korda ööpäevas
English: 3.5 to 10.5 mg /kg (0.035 to 0.105 ml/kg) twice daily
Estonian: 3,5...10,5 mg/kg (0,035...0,105 ml/kg) kaks korda ööpäevas
English: Levetiracetam Accord 1000 mg film-coated tablets White to off white, oval, biconvex, debossed ‘L 67' and break line on one side and plain on the other side.
Estonian: Levetiracetam Accord 1000 mg õhukese polümeerikattega tabletid Valge kuni valkjas, ovaalse kujuga kaksikkumer tablett, mille ühele küljele on pressitud märgistus „L67” ja poolitusjoon.
English: 10 to 30 mg /kg (0.10 to 0.30 ml/kg) twice daily
Estonian: 10...30 mg/kg (0,10...0,30 ml/kg) kaks korda ööpäevas
English: Levetiracetam Accord 750 mg film-coated tablets Each film-coated tablet contains 750 mg levetiracetam
Estonian: Levetiracetam Accord 750 mg õhukese polümeerikattega tabletid Üks õhukese polümeerikattega tablett sisaldab 750 mg levetiratsetaami.
English: INFORMATION IN BRAILLE Levetiracetam Accord 500 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Levetiracetam Accord 500 mg
English: Levetiracetam Accord 250 mg film-coated tablets Each film-coated tablet contains 250 mg levetiracetam
Estonian: Levetiracetam Accord 250 mg õhukese polümeerikattega tabletid Üks õhukese polümeerikattega tablett sisaldab 250 mg levetiratsetaami.
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam Accord 1000 mg film-coated tablets Levetiracetam STATEMENT OF ACTIVE SUBSTANCE (S) Each film-coated tablet contains 1000 mg levetiracetam.
Estonian: Levetiracetam Accord 1000 mg õhukese polümeerikattega tabletid Üks õhukese polümeerikattega tablett sisaldab 1000 mg levetiratsetaami.
English: 5 to 10 mg /kg (0.05 to 0.10 ml/kg) twice daily
Estonian: 5...10 mg/kg (0,05...0,10 ml/kg) kaks korda ööpäevas
English: CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription.
Estonian: B. HANKE- JA KASUTUSTINGIMUSED VÕI PIIRANGUD C. MÜÜGILOA MUUD TINGIMUSED JA NÕUDED D. RAVIMPREPARAADI OHUTU JA EFEKTIIVSE KASUTAMISE
English: White to off white, oval, biconvex, film coated tablet, debossed ‘L 64' and break line on one side and plain on the other side.
Estonian: Valge kuni valkjas, ovaalse kujuga kaksikkumer õhukese polümeerikattega tablett, mille ühele küljele on pressitud märgistus „L64” ja poolitusjoon.
English: Duration of treatment - Levetiracetam Accord is used as a chronic treatment.
Estonian: • Levetiracetam Accord'i kasutatakse n.ö pikaajalises ravis.
English: [140-age (years)] x weight (kg) CLcr (ml/min) = ----------------------------------------- (x 0.85 for women) 72 x serum creatinine (mg/dl)
Estonian: 72 x seerumi kreatiniinisisaldus (mg/dl)
English: White to off white, oval, biconvex, film coated tablet, debossed ‘L 67' and break line on one side and plain on the other side.
Estonian: Valge kuni valkjas, ovaalse kujuga kaksikkumer õhukese polümeerikattega tablett, mille ühele küljele on pressitud märgistus „L67” ja poolitusjoon.
English: Uncommon: may affect up to 1 in 100 people
Estonian: Aeg-ajalt (võib esineda kuni ühel inimesel 100-st):
English: Levetiracetam Accord 750 mg film-coated tablets Levetiracetam
Estonian: Levetiracetam Accord 750 mg õhukese polümeerikattega tabletid Levetiratsetaam
English: EU/1/11/712/015-021 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/035-037 (30/60/100tablets in Unit dose Blister)
Estonian: EU/1/11/712/015-021 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/035-037 (30/60/100 tabletti üheannuselises blisterpakendis)
English: Amnesia, memory impairment, coordination abnormal/ataxia, paraesthesia,disturbance in attention
Estonian: treemor koordinatsioon/ataksia, paresteesia, tähelepanuhäire hüperkineesia, kõnnakuhäired, entsefalopaatia
English: Convulsion, balance disorder, dizziness, lethargy, tremor
Estonian: Krambid, tasakaaluhäire, pearinglus, letargia,
English: EU/1/11/712/001-007 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/029-031(30/60/100 tablets in Unit dose Blister)
Estonian: EU/1/11/712/001-007 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/029-031(30/60/100 tabletti üheannuselises blisterpakendis)
English: Pink coloured, oval, biconvex, film coated tablet, debossed ‘L 66' and break line on one side and plain on the other side.
Estonian: Roosa, ovaalse kujuga kaksikkumer õhukese polümeerikattega tablett, mille ühele küljele on pressitud märgistus „L66” ja poolitusjoon.
English: Levetiracetam Accord 250 mg film-coated tablets Levetiracetam
Estonian: Levetiracetam Accord 250 mg õhukese polümeerikattega tabletid Levetiratsetaam
English: Yellow coloured, oval, biconvex, film coated tablet, debossed ‘L 65' and break line on one side and plain on the other side.
Estonian: Kollane, ovaalse kujuga kaksikkumer õhukese polümeerikattega tablett, mille ühele küljele on pressitud märgistus „L65” ja poolitusjoon.
English: EU/1/11/712/008-014 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/032-034 (30/60/100tablets in Unit dose Blister)
Estonian: EU/1/11/712/008-014 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/032-034 (30/60/100 tabletti üheannuselises blisterpakendis)
English: EU/1/11/712/022-028 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/038-040(30/60/100tablets in Unit dose Blister)
Estonian: EU/1/11/712/022-028 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/038-040(30/60/100 tabletti üheannuselises blisterpakendis)
English: Levetiracetam oral solution is the preferred formulation for use in this population.
Estonian: Selles vanuserühmas eelistada levetiratsetaami suukaudset lahust.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/712/015-021 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/035-037 (30/60/100tablets in Unit dose Blister)
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/11/712/015-021 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/035-037 (30/60/100 tabletti üheannuselises blisterpakendis)
English: Levetiracetam Accord 1000 mg film-coated tablet Levetiracetam
Estonian: Levetiracetam Accord 1000 mg õhukese polümeerikattega tabletid Levetiratsetaam
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/712/001-007 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/029-031(30/60/100tablets in Unit dose Blister)
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/11/712/001-007 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/029-031(30/60/100 tabletti üheannuselises blisterpakendis)
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/712/022-028 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/038-040 (30/60/100tablets in Unit dose Blister)
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/11/712/022-028 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/038-040 (30/60/100 tabletti üheannuselises blisterpakendis)
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/712/008-014 (10/20/30/50/60/100/200 tablets in PVC/alu Blister) EU/1/11/712/032-034 (30/60/100tablets in Unit dose Blister)
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/11/712/008-014 (10/20/30/50/60/100/200 tabletti PVC/alu blisterpakendis) EU/1/11/712/032-034 (30/60/100 tabletti üheannuselises blisterpakendis)
English: If you stop taking Levetiracetam Accord
Estonian: Ärge võtke ravimit Levetiracetam Accord